Friedrich Raulf

3.4k total citations
49 papers, 2.7k citations indexed

About

Friedrich Raulf is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Friedrich Raulf has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Friedrich Raulf's work include Neuroendocrine Tumor Research Advances (13 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Receptor Mechanisms and Signaling (6 papers). Friedrich Raulf is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Renal Transplantation Outcomes and Treatments (9 papers) and Receptor Mechanisms and Signaling (6 papers). Friedrich Raulf collaborates with scholars based in Switzerland, Germany and United States. Friedrich Raulf's co-authors include Manfred Schartl, Christian Bruns, Daniël Hoyer, Rudolf Götz, Gisbert Weckbecker, Hermann Lübbert, Reinhard W. Köster, Christoph Winkler, H. Thoenen and Friedrich Lottspeich and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Friedrich Raulf

49 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friedrich Raulf Switzerland 26 1.0k 786 540 502 388 49 2.7k
Masayuki Komada Japan 37 3.0k 2.9× 498 0.6× 750 1.4× 451 0.9× 382 1.0× 80 4.8k
Christiane Susini France 40 1.7k 1.6× 2.1k 2.6× 1.4k 2.6× 339 0.7× 236 0.6× 87 4.1k
Sara Mole United Kingdom 41 3.0k 2.9× 1.1k 1.5× 565 1.0× 432 0.9× 282 0.7× 147 7.2k
Jorge Laborda Spain 39 2.9k 2.8× 453 0.6× 496 0.9× 170 0.3× 542 1.4× 86 4.4k
Marc Billaud France 38 3.2k 3.1× 603 0.8× 1.3k 2.4× 403 0.8× 419 1.1× 84 5.1k
Claus Munck Petersen Denmark 33 1.7k 1.7× 227 0.3× 248 0.5× 1.0k 2.0× 428 1.1× 69 3.6k
Hirokazu Kotani Japan 23 1.8k 1.7× 248 0.3× 300 0.6× 553 1.1× 214 0.6× 74 2.9k
Tiziana Crepaldi Italy 28 1.5k 1.5× 200 0.3× 416 0.8× 205 0.4× 279 0.7× 70 2.9k
Ituro Inoue Japan 35 1.5k 1.4× 229 0.3× 383 0.7× 226 0.5× 475 1.2× 101 3.6k
Carmen Ruiz de Almodóvar Germany 30 1.7k 1.7× 208 0.3× 504 0.9× 583 1.2× 402 1.0× 55 3.3k

Countries citing papers authored by Friedrich Raulf

Since Specialization
Citations

This map shows the geographic impact of Friedrich Raulf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Raulf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Raulf more than expected).

Fields of papers citing papers by Friedrich Raulf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Raulf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Raulf. The network helps show where Friedrich Raulf may publish in the future.

Co-authorship network of co-authors of Friedrich Raulf

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Raulf. A scholar is included among the top collaborators of Friedrich Raulf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Raulf. Friedrich Raulf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millar, Neal L., Iain B. McInnes, Frank Kolbinger, et al.. (2025). Targeting the IL-17A pathway for therapy in early-stage tendinopathy. RMD Open. 11(1). e004729–e004729. 2 indexed citations
2.
Uluçkan, Özge, Dominique Fehlmann, Holger Stark, et al.. (2023). Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in mice. European Journal of Pharmacology. 945. 175533–175533. 6 indexed citations
3.
Caduff, Nicole, Donal McHugh, Anita Murer, et al.. (2020). Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathogens. 16(4). e1008477–e1008477. 16 indexed citations
4.
Penno, Carlos A., Andreas Hofmann, Dirk J. Schaefer, et al.. (2020). Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. Journal of Investigative Dermatology. 140(12). 2421–2432.e10. 40 indexed citations
5.
Raulf, Friedrich, et al.. (2013). Size Fractionation of Microscopic Protein Aggregates Using a Preparative Fluorescence-Activated Cell Sorter. Journal of Pharmaceutical Sciences. 102(7). 2128–2135. 5 indexed citations
6.
Haan, Claude, Catherine Rolvering, Friedrich Raulf, et al.. (2011). Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors. Chemistry & Biology. 18(3). 314–323. 154 indexed citations
7.
Scherer, Andreas, Friedrich Raulf, Céline C. Berthier, et al.. (2009). Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes. American Journal of Transplantation. 9(3). 517–526. 53 indexed citations
8.
Scherer, Andreas, Wilfried Gwinner, Michael Mengel, et al.. (2009). Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrology Dialysis Transplantation. 24(8). 2567–2575. 35 indexed citations
9.
Scherer, Andreas, Meike Körner, Ute Eisenberger, et al.. (2009). Meta-Analyses Qualify Metzincins and Related Genes as Acute Rejection Markers in Renal Transplant Patients. American Journal of Transplantation. 10(2). 286–297. 22 indexed citations
10.
Saint-Mézard, Pierre, Céline C. Berthier, Hai Zhang, et al.. (2008). Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transplant International. 22(3). 293–302. 66 indexed citations
11.
Berthier, Céline C., Simone A. Joosten, Cees van Kooten, et al.. (2006). Differential regulation of metzincins in experimental chronic renal allograft rejection: Potential markers and novel therapeutic targets. Kidney International. 69(2). 358–368. 31 indexed citations
12.
Blancher, Antoine, Pierre Tisseyre, Marianne Dutaur, et al.. (2006). Study of Cynomolgus monkey (Macaca fascicularis) MhcDRB (Mafa-DRB) polymorphism in two populations. Immunogenetics. 58(4). 269–282. 55 indexed citations
13.
Hueso, Miguel, Jordi Bover, Francesc Moreso, et al.. (2001). TGF-β1 gene expression in protocol biopsies from patients with stable renal allograft function. Transplantation Proceedings. 33(1-2). 342–344. 2 indexed citations
14.
Clemens, Andreas, M. S. Klevesath, M. Hofmann, et al.. (1999). Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus. Metabolism. 48(10). 1236–1240. 20 indexed citations
15.
Schloos, J., Friedrich Raulf, Daniël Hoyer, & Christian Bruns. (1997). Identification and pharmacological characterization of somatostatin receptors in rat lung. British Journal of Pharmacology. 121(5). 963–971. 23 indexed citations
16.
Bruns, Christian, Friedrich Raulf, Daniël Hoyer, et al.. (1996). Binding properties of somatostatin receptor subtypes. Metabolism. 45(8 Suppl 1). 17–20. 104 indexed citations
17.
Weckbecker, Gisbert, et al.. (1996). Potentiation of the Anti-Proliferative Effects of Anti-Cancer Drugs by Octreotide in vitro and in vivo. Digestion. 57(1). 22–28. 41 indexed citations
18.
Götz, Rudolf, Reinhard W. Köster, Christoph Winkler, et al.. (1994). Neurotrophin-6 is a new member of the nerve growth factor family. Nature. 372(6503). 266–269. 313 indexed citations
19.
Brander, Christian, et al.. (1994). Molecular Pharmacology of Somatostatin‐receptor Subtypes. Annals of the New York Academy of Sciences. 733(1). 138–146. 114 indexed citations
20.
Wittbrodt, Joachim, Dieter Adam, Barbara Malitschek, et al.. (1989). Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature. 341(6241). 415–421. 264 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Komada Breakdown of academic impact, for papers by Christiane Susini Breakdown of academic impact, for papers by Sara Mole Breakdown of academic impact, for papers by Jorge Laborda Breakdown of academic impact, for papers by Marc Billaud Breakdown of academic impact, for papers by Claus Munck Petersen Breakdown of academic impact, for papers by Hirokazu Kotani Breakdown of academic impact, for papers by Tiziana Crepaldi Breakdown of academic impact, for papers by Ituro Inoue Breakdown of academic impact, for papers by Carmen Ruiz de Almodóvar
Rankless by CCL
2026